Steven R Hirsch , Rahul Manchanda , Malcolm P.I Weller
{"title":"Dextro-propranolol in schizophrenia","authors":"Steven R Hirsch , Rahul Manchanda , Malcolm P.I Weller","doi":"10.1016/0364-7722(81)90106-5","DOIUrl":null,"url":null,"abstract":"<div><p></p><ul><li><span>1.</span><span><p>1. Nine schizophrenic patients with florid symptoms were treated openly with d-propranolol. The mean dose was 1329 mg/day and the mean duration of treatment was 3.1 weeks.</p></span></li><li><span>2.</span><span><p>2. Results showed seven out of nine patients improved. Significant change in the schizophrenia subscore of BPRS was observed. Side effects of concern were seen in two patients.</p></span></li><li><span>3.</span><span><p>3. The implications of this therapeutic effect are discussed.</p></span></li></ul></div>","PeriodicalId":20801,"journal":{"name":"Progress in neuro-psychopharmacology","volume":"4 6","pages":"Pages 633-637"},"PeriodicalIF":0.0000,"publicationDate":"1981-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/0364-7722(81)90106-5","citationCount":"12","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Progress in neuro-psychopharmacology","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/0364772281901065","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 12
Abstract
1.
1. Nine schizophrenic patients with florid symptoms were treated openly with d-propranolol. The mean dose was 1329 mg/day and the mean duration of treatment was 3.1 weeks.
2.
2. Results showed seven out of nine patients improved. Significant change in the schizophrenia subscore of BPRS was observed. Side effects of concern were seen in two patients.
3.
3. The implications of this therapeutic effect are discussed.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
